Macrophages in the BM of MPN patients have recently gained increased clinical attention, as they have been shown to be attractive novel cellular therapeutic targets, particularly as they play a significant role in inducing proliferating myofibroblasts via vitamin D receptor signaling [8]. The gene discussed is VDR; the disease is myeloproliferative neoplasm.